Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» pemigatinib
pemigatinib
Incyte nabs 2nd ever approval ahead of schedule as FDA insists it can still review on time
Endpoints
Mon, 04/20/20 - 10:58 am
Incyte
Pemazyre
pemigatinib
bile duct cancer
cholangiocarcinoma
FDA
Can Jakafi hit $3B? Incyte thinks so—and it's got other launches on the way
Fierce Pharma
Thu, 02/13/20 - 11:28 pm
Incyte
Jakafi
pemigatinib
FDA accepts Incyte’s NDA for priority review of pemigatinib to treat cholangiocarcinoma
Pharmaceutical Business Review
Fri, 11/29/19 - 02:24 pm
FDA
Incyte
priority review
pemigatinib
cholangiocarcinoma
Innovent, Incyte sign collaboration deal for three clinical-stage product candidates
Pharmaceutical Business Review
Mon, 12/17/18 - 09:02 am
Incyte
Innovent Biologics
pemigatinib
itacitinib
parsaclisib